LLYVA:NASDAQLiberty Live Holdings, Inc. - Series A Liberty Live Group Analysis
Data as of 2026-06-09 - not real-time
$89.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Liberty Live Holdings (LLYVA) trades at $89.65, just above its 200‑day SMA of $88.78 but below the 20‑day ($94.58) and 50‑day ($93.65) averages, indicating short‑term weakness despite a bullish overall trend. The RSI of 39.9 suggests the stock is approaching oversold territory, while a bearish MACD (line –0.70 vs signal 0.13) reinforces downside pressure. Price sits near the identified support level of $87.44 and faces resistance around $99.16. On the fundamentals side, revenue surged 35% YoY to $398.5 M, yet margins remain deeply negative (gross 20%, operating –26%, profit –88%) and the company carries $1.82 B of debt against $524 M of cash, resulting in a negative book value per share. Forward earnings are projected at $1.86 per share, implying a forward P/E of 48.2, far above the industry average of 16.9, while price‑to‑sales stands at 20.7. The Fear & Greed Index at 87.6 (“Extreme Greed”) reflects strong market optimism, but the underlying financials tell a more cautious story.
In summary, the stock is technically near a critical support zone with mixed signals, fundamentally overvalued given its loss profile and debt load, yet it benefits from robust revenue growth and a substantial cash cushion that could support a turnaround if profitability improves.
In summary, the stock is technically near a critical support zone with mixed signals, fundamentally overvalued given its loss profile and debt load, yet it benefits from robust revenue growth and a substantial cash cushion that could support a turnaround if profitability improves.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price testing support at $87.44
- bearish MACD and sub‑SMA20 price
- high forward P/E relative to industry
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- 35% revenue growth indicating top‑line momentum
- projected positive forward EPS
- substantial cash buffer offsetting debt concerns
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- potential earnings turnaround if margins improve
- ongoing exposure to discretionary entertainment demand
- persistent high valuation and negative equity limiting upside
Key Metrics & Analysis
Financial Health
Revenue Growth35.20%
Profit Margin-88.23%
P/E Ratio48.2
ROA-2.05%
P/B Ratio-26.0
Op. Cash Flow$-21615000
Industry P/E16.9
Technical Analysis
TrendBullish
RSI39.9
Support$87.44
Resistance$99.16
MA 20$94.58
MA 50$93.65
MA 200$88.78
MACDBearish
VolumeStable
Fear & Greed Index87.64
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.84
Volatility29.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.